Join Growin Stock Community!

National healthcare corporationNHC.US Overview

US StockHealthcare
(No presentation for NHC)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

NHC AI Insights

NHC Overall Performance

NHC AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

NHC Recent Performance

3.97%

National healthcare corporation

0.05%

Avg of Sector

-0.31%

S&P500

NHC PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

NHC Key Information

NHC Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

NHC Profile

National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living centers offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. It also offers behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, it provides health care programs that offer skilled services, such as infusion, wound care and physical, occupational, and speech therapies; hospice care services; operates pharmacies; offers management, accounting, financial, and insurance services; and leases its properties to third party operators. As of February 18, 2022, the company operated 75 skilled nursing facilities with 9,473 beds, 24 assisted living facilities, five independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee.

Price of NHC

NHC FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

NHC Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
7.74
PE Ratio (TTM)
19.54
Forward PE
-
PS Ratio (TTM)
1.67
PB Ratio
2.36
Price-to-FCF
17.87
METRIC
VALUE
vs. INDUSTRY
Gross Margin
100.00%
Net Margin
7.91%
Revenue Growth (YoY)
16.09%
Profit Growth (YoY)
16.09%
3-Year Revenue Growth
13.47%
3-Year Profit Growth
13.47%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
7.74
PE Ratio (TTM)
19.54
Forward PE
-
PS Ratio (TTM)
1.67
PB Ratio
2.36
Price-to-FCF
17.87
Gross Margin
100.00%
Net Margin
7.91%
Revenue Growth (YoY)
16.09%
Profit Growth (YoY)
16.09%
3-Year Revenue Growth
13.47%
3-Year Profit Growth
13.47%

  • When is NHC's latest earnings report released?

    The most recent financial report for National healthcare corporation (NHC) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating NHC's short-term business performance and financial health. For the latest updates on NHC's earnings releases, visit this page regularly.

  • Where does NHC fall in the P/E River chart?

    According to historical valuation range analysis, National healthcare corporation (NHC)'s current price-to-earnings (P/E) ratio is 20.74, placing it in the Reasonable zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of NHC?

    According to the latest financial report, National healthcare corporation (NHC) reported an Operating Profit of 33.12M with an Operating Margin of 8.57% this period, representing a growth of 14.55% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is NHC's revenue growth?

    In the latest financial report, National healthcare corporation (NHC) announced revenue of 386.51M, with a Year-Over-Year growth rate of 4.65%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does NHC have?

    As of the end of the reporting period, National healthcare corporation (NHC) had total debt of 87.07M, with a debt ratio of 0.06. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does NHC have?

    At the end of the period, National healthcare corporation (NHC) held Total Cash and Cash Equivalents of 110.95M, accounting for 0.07 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does NHC go with three margins increasing?

    In the latest report, National healthcare corporation (NHC) achieved the “three margins increasing” benchmark, with a gross margin of 100%%, operating margin of 8.57%%, and net margin of 6.4%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess NHC's profit trajectory and future growth potential.

  • Is NHC's EPS continuing to grow?

    According to the past four quarterly reports, National healthcare corporation (NHC)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.61. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of NHC?

    National healthcare corporation (NHC)'s Free Cash Flow (FCF) for the period is 6.41M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 4.8% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of NHC?

    The latest valuation data shows National healthcare corporation (NHC) has a Price-To-Earnings (PE) ratio of 20.74 and a Price/Earnings-To-Growth (PEG) ratio of -0.59. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.